The historic rise of Viagra has long been a symbol of pharmaceutical success, yet its position within the broader sector now presents questions about potential gains. Copycat versions are eroding exclusivity , leading to anxieties that investing in companies significantly dependent to Viagra's once-dominant position could be a dangerous decision… Read More